Not even COVID-19 can put the brakes on the Facebook (FB) juggernaut. The social media giant reported earnings last Wednesday and investors liked what they saw.So did Rosenblatt’s Mark Zgutowicz. So much so, the 5-star analyst reiterated a Buy rating on Facebook shares, while increasing the price target from $223 to $244. The figure implies upside of 19% from current levels. (To watch Zgutowicz’s track record, click here)Heading into Facebook’s quarterly statement, all eyes were on two COVID-19 driven metrics: increased user engagement, and at the opposite end, reduced ad spend. Facebook delivered on both and at the same time …read more
Source:: Yahoo Finance
